Pattern Dystrophies: A Guide to This Inherited Retinal Condition
Understanding Pattern Dystrophies
Pattern dystrophies are a family of related macular diseases. They share a common feature: pigment deposits form distinctive patterns in the RPE layer of the macula. The RPE is a thin layer of cells that supports and nourishes the light-sensing photoreceptor cells above it. When the RPE does not work properly, waste products build up and can damage vision over time.
There are several recognized types of pattern dystrophy. These include butterfly-shaped pigment dystrophy, adult-onset foveomacular vitelliform dystrophy (AOFVD), reticular dystrophy, fundus pulverulentus, and multifocal pattern dystrophy simulating Stargardt disease. Each type creates a slightly different pattern of pigment deposits, but they share similar causes and outcomes.
The RPE plays a critical role in clearing waste from the retina. In pattern dystrophies, genetic mutations disrupt this process. This leads to a buildup of a fatty substance called lipofuscin. Lipofuscin accumulates in the RPE cells and can gradually interfere with retinal health.
Research has linked many pattern dystrophies to mutations in the PRPH2 gene, also known as the RDS gene. This gene provides instructions for making a protein called peripherin-2. Peripherin-2 helps build and stabilize the outer segments of photoreceptor cells. When this protein does not function correctly, photoreceptor membranes break down. Over time, photoreceptor cells degenerate and lipofuscin accumulates in the RPE.
Each subtype of pattern dystrophy has a characteristic appearance when viewed during an eye examination. Understanding these types can help when discussing your diagnosis with a retina specialist.
- Butterfly-shaped pigment dystrophy: Pigment deposits at the macula form a shape resembling butterfly wings.
- Adult-onset foveomacular vitelliform dystrophy (AOFVD): A round, egg-yolk-like deposit forms at the center of the macula, typically appearing in middle age.
- Reticular dystrophy: A net-like or fishnet pattern of pigment appears across the macula.
- Fundus pulverulentus: Fine, scattered pigment granules spread across the back of the eye.
- Multifocal pattern dystrophy simulating Stargardt disease: Multiple yellowish deposits across the macula resemble a different inherited condition.
Who Is Affected and Risk Factors
Pattern dystrophies are inherited conditions. Most follow an autosomal dominant inheritance pattern. This means a person with the condition has a one-in-two chance of passing it to each child (GeneReviews, NIH). Only one copy of the mutated gene is needed to develop the condition. Both males and females are affected equally.
The most commonly involved gene is PRPH2, but other genes have also been identified, including ABCA4, VMD2, and IMPG1. Genetic testing can help identify the specific mutation involved. This information may be useful for family planning discussions and future treatment options.
Pattern dystrophies typically appear later in life than many other inherited retinal diseases. Most people first notice symptoms or receive a diagnosis between the ages of 40 and 60. The age at presentation can range from 40 to 90 years. Because symptoms often develop gradually, many people live with the condition for years before it is detected.
Certain systemic conditions have been linked to pattern dystrophies. Maternally inherited diabetes and deafness (MIDD) shows a high correlation. Pattern dystrophy features appear in up to 85 percent of individuals with MIDD (GeneReviews, NIH). Pseudoxanthoma elasticum, a connective tissue disorder, has been observed across all subtypes. Butterfly and reticular dystrophy have also been linked to myotonic dystrophy.
Pattern dystrophies are more common than many people realize. One study estimated the prevalence in northern France at approximately 1 in 1,490 individuals, with over 300,000 affected people across greater Europe (GeneReviews, NIH). Adult-onset foveomacular vitelliform dystrophy specifically may affect up to 1 in 7,400 individuals (PMC, NIH, 2017).
Signs and Symptoms
The most common early symptoms of pattern dystrophy are metamorphopsia (distorted or wavy vision) and a mild decrease in central visual sharpness. Many people notice that straight lines appear bent or that fine details become harder to see. These changes often develop so gradually that they may go unnoticed for some time.
Because symptoms can be very mild, pattern dystrophies are frequently discovered during routine eye examinations. The average visual acuity at the time of diagnosis is approximately 20/40. This means most people still see relatively well when the condition is first identified.
The symptoms of pattern dystrophy closely resemble those of age-related macular degeneration (AMD). However, pattern dystrophy symptoms tend to be less severe. This similarity can lead to diagnostic confusion, especially when the condition first presents in older adults. A retina specialist can distinguish between the two conditions using specialized imaging and testing.
About 15 percent of people with pattern dystrophies develop new, leaky blood vessels in the retina (Macular Society). A similar proportion may develop geographic atrophy, where patches of light-sensing cells die off. If you experience a sudden increase in distorted vision, new dark spots in your central vision, or a rapid decline in visual sharpness, see a retina specialist or go to the emergency room immediately. These changes could signal a complication that needs prompt treatment.
Diagnosis and Testing
Diagnosing pattern dystrophy begins with a thorough dilated eye examination. A retina specialist will look at the macula for the characteristic pigment patterns. Because these patterns can resemble AMD, additional testing is usually needed to confirm the diagnosis.
Several imaging technologies help retina specialists evaluate pattern dystrophies in detail. These tests take only a few minutes.
- Optical coherence tomography (OCT): This scan creates detailed cross-sectional images of the retina, showing the layers of tissue and any deposits or structural changes.
- Fundus autofluorescence (FAF): This imaging technique highlights lipofuscin deposits in the RPE, revealing the distinctive patterns that give these conditions their name.
- Fluorescein angiography: A special dye is injected into a vein in the arm and photographed as it passes through the retinal blood vessels, helping detect any abnormal leaking vessels.
Electroretinography (ERG) and electrooculography (EOG) measure the electrical responses of retinal cells. In pattern dystrophies, the full-field ERG is usually normal or near-normal. The EOG may show mild abnormalities. These tests help differentiate pattern dystrophies from other retinal conditions that may look similar.
Genetic testing can identify the specific gene mutation responsible for a pattern dystrophy. This information is valuable for confirming the diagnosis and understanding the inheritance pattern. It also helps determine whether a person may be eligible for future gene-based therapies. A retina specialist or genetic counselor can discuss whether genetic testing is appropriate.
Treatment Options
There is currently no treatment that can reverse or stop the underlying progression of pattern dystrophies. Because these conditions progress slowly, most people maintain useful vision for many years. Treatment focuses on monitoring and managing complications when they arise.
Pattern dystrophies can sometimes lead to the growth of abnormal, leaky blood vessels beneath the retina. This complication is called choroidal neovascularization (CNV). It is distinct from AMD, even though both conditions can involve CNV. Anti-VEGF (vascular endothelial growth factor) therapy blocks the signals that drive abnormal blood vessel growth and leakage.
Studies have shown successful use of Lucentis (ranibizumab) and Avastin (bevacizumab) for CNV caused by pattern dystrophies. Avastin is FDA-approved for the treatment of certain cancers and is used off-label for retinal conditions. Other anti-VEGF options such as Eylea (aflibercept) and Vabysmo (faricimab) may also be considered. These injections are given directly into the eye at intervals determined by the retina specialist based on the individual response. It is important to note that anti-VEGF injections are used specifically for wet AMD and are not a treatment for dry AMD.
For many people with pattern dystrophies, regular monitoring is the most appropriate approach. A retina specialist will schedule periodic examinations and imaging to track any changes. Home monitoring with an Amsler grid, a simple chart of straight lines, can help you detect new distortion or blind spots between appointments.
If central vision loss does progress, low vision rehabilitation services can help maximize remaining vision. Magnifying devices, specialized lighting, and adaptive technology can make daily activities easier. A retina specialist can provide referrals to low vision services when appropriate.
What to Expect
The visual outlook for most people with pattern dystrophies is generally favorable. These conditions tend to progress slowly over decades. Many people maintain functional central vision well into later life. The course can vary depending on the specific subtype and the gene mutation involved.
Because complications like CNV or geographic atrophy can develop at any time, ongoing follow-up with a retina specialist is essential. Many people are seen once or twice a year when the condition is stable. More frequent visits are scheduled if changes are detected.
Receiving a diagnosis of an inherited retinal condition can bring complex emotions. Worry about your own vision and concern about passing the condition to children are common. Support groups, genetic counseling, and open conversations with your retina specialist can help. Organizations such as the Foundation Fighting Blindness offer resources for people living with inherited retinal diseases.
Living With Pattern Dystrophies
Most people with pattern dystrophies continue their normal daily activities without major limitations. This is especially true in the early and middle stages. Good lighting, reading glasses or magnifiers, and increased font sizes on digital devices can help. Wearing sunglasses outdoors may reduce glare and improve visual comfort.
Because most pattern dystrophies follow an autosomal dominant inheritance pattern, family members may wish to be screened. Each child of an affected parent has a one-in-two chance of carrying the same gene mutation (GeneReviews, NIH). A retina specialist or genetic counselor can help family members understand their risk. Early identification allows for timely monitoring even before symptoms appear.
Research into pattern dystrophies is ongoing. Gene therapy aims to correct the underlying genetic defects responsible for these conditions. Researchers are working on therapies targeting mutations in the PRPH2 gene. The goal is to deliver functional copies of the gene to retinal cells. These therapies remain in the research stage and are not yet available for clinical use. Staying connected with a retina specialist can help you learn about clinical trials as they become available.
When to See a Retina Specialist
If you have a family history of pattern dystrophy or any inherited retinal disease, a baseline evaluation with a retina specialist is recommended. This applies even if you have no symptoms. An initial examination can establish a reference point for future comparisons and detect early changes.
Contact a retina specialist promptly or seek emergency care if you experience any of the following changes.
- A sudden increase in wavy or distorted vision
- New dark or blank spots in the center of your vision
- A rapid decline in the sharpness of your central vision
- Flashes of light or a sudden increase in floaters
These symptoms may indicate choroidal neovascularization or other complications that benefit from early treatment. Prompt evaluation can make a significant difference in preserving vision.
Even when your condition is stable, regular visits with a retina specialist help ensure that any changes are caught early. Your specialist can adjust your monitoring schedule based on your specific situation. Consistent follow-up is one of the most important steps you can take to protect your vision.
Questions and Answers
Yes, this is a common source of diagnostic confusion, especially in older adults. Both conditions affect the macula and can cause similar symptoms. However, pattern dystrophies are genetically inherited and often begin earlier in life than AMD. A retina specialist can use specialized imaging, electrophysiology testing, and family history to distinguish between the two. Accurate diagnosis matters because the long-term outlook and management strategies differ.
Because most pattern dystrophies are inherited in an autosomal dominant pattern, each child of an affected parent has a one-in-two chance of inheriting the gene mutation (GeneReviews, NIH). Genetic testing and a baseline retinal examination can help identify family members who carry the mutation. Early detection allows for monitoring that can catch complications sooner. A genetic counselor can help your family weigh the benefits and limitations of testing.
Most people with pattern dystrophies maintain functional central vision for many years. Some retain good vision throughout their lives. The conditions tend to progress slowly, and the average visual acuity at diagnosis is around 20/40. However, some patients do experience more significant central vision loss if complications develop. Regular monitoring with a retina specialist is the best way to detect and address complications early.
Gene therapy for pattern dystrophies is currently in the research stage. Scientists are working on approaches to deliver functional copies of the PRPH2 gene to retinal cells. However, no gene therapy is currently approved for pattern dystrophies. Staying in contact with a retina specialist can help you learn about clinical trials that may be relevant to your specific genetic mutation as the field advances.
The different types are distinguished primarily by the shape and distribution of pigment deposits in the RPE. Butterfly-shaped pigment dystrophy creates deposits resembling butterfly wings. Reticular dystrophy forms a net-like pattern. Adult-onset foveomacular vitelliform dystrophy produces a round, egg-yolk-shaped deposit at the center of the macula. Despite their different appearances, all subtypes share similar genetic causes and a generally slow course of progression.